Advanced search
54
Views
3
CrossRef citations to date
0
Altmetric
Retina &Choroid

miR-340 Exerts Suppressive Effect on Retinoblastoma Progression by Targeting KIF14

, , , , &
Pages 232-238
Received 27 Aug 2019
Accepted 03 Jul 2020
Published online: 06 Aug 2020
 

ABSTRACT

Purpose: This work aimed to investigate the influences of microRNA-340 (miR-340) on proliferation and apoptosis of retinoblastoma (RB) cells and explore its regulatory mechanism.

Materials and Methods

miR-340 mimic and inhibitor were applied for up-regulating or inhibiting the expression of miR-340 in RB cell lines. Then, CCK-8 and AnnexinV-FITC/PI staining were used to measure cell proliferation and apoptosis, respectively. After that, luciferase assay was performed to affirm the direct targets of miR-340. Furthermore, qRT-PCR and western blotting assay were carried out to detect the levels of miR-340 and KIF14.

Results

Our results indicated that the miR-340 was lowly expressed in RB cell lines, and up-regulation of miR-340 can decrease the proliferation and induce the apoptosis of RB cells. Moreover, we verified that miR-340 controls KIF14 expression, either directly or through a subsequent molecular cascade, and inversely related to its expression. The results obtained from the rescue assays presented that over-expression of KIF14 reversed the miR-340-mediated inhibition on malignant phenotype of RB cells.

Conclusions

Overall, we proved that miR-340 can decrease the proliferation and increase the apoptosis of RB cells, and its function in RB cells was at least partially achieved via down-regulation of KIF14, prompting that miR-340 was expected to supply a new direction for clinical therapy of RB in the future.

Acknowledgments

We thank the Dezhou People’s Hospital for providing the research platform.

Disclosure statement

Hong-Kun Xu declares that he has no conflict of interest. Xiao-Dong Wang declares that he has no conflict of interest. De-Gong Wang declares that he has no conflict of interest. Dong-Dong Wei declares that he has no conflict of interest. Ling Liang declares that she has no conflict of interest. Chang-Hui Liu declares that he has no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Funding

No funding was received in this study.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
EUR 51.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
EUR 384.00 Add to cart

Purchase access via tokens

  • Choose from packages of 10, 20, and 30 tokens
  • Can use on articles across multiple libraries & subject collections
  • Article PDFs can be downloaded & printed
From EUR 400.00
per package
Learn more
* Local tax will be added as applicable
 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.